Clinical Trial Update: Curcuma Longa L in Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Curcuma longa L. (turmeric) for rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Curcuma longa L. (turmeric extract)

Snippet

Sponsor: University of Arizona | Conditions: Rheumatoid Arthritis | Phase 1 | Status: TERMINATED